RU2011103476A - Нифуртимокс для лечения болезней, вызванных трихомонадидами - Google Patents
Нифуртимокс для лечения болезней, вызванных трихомонадидами Download PDFInfo
- Publication number
- RU2011103476A RU2011103476A RU2011103476/15A RU2011103476A RU2011103476A RU 2011103476 A RU2011103476 A RU 2011103476A RU 2011103476/15 A RU2011103476/15 A RU 2011103476/15A RU 2011103476 A RU2011103476 A RU 2011103476A RU 2011103476 A RU2011103476 A RU 2011103476A
- Authority
- RU
- Russia
- Prior art keywords
- treatment
- diseases caused
- nifurtimox
- use according
- trihomonadides
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
- A61K31/541—Non-condensed thiazines containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/15—Depsipeptides; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/10—Anthelmintics
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Tropical Medicine & Parasitology (AREA)
- General Chemical & Material Sciences (AREA)
- Gastroenterology & Hepatology (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Immunology (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Fodder In General (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
1. Применение нифуртимокса для получения лекарственных средств для лечения болезней, вызванных трихомонадидами. ! 2. Применение по п.1 для лечения болезней, вызванных гистомонадами. ! 3. Применение по п.2 для лечения болезней, вызванных Histomonas meleagridis. ! 4. Применение по п.1 для лечения болезней, вызванных трихомонадами. ! 5. Применение по п.1 для лечения болезней, вызванных тритрихомонадами. ! 6. Нифуртимокс для применения в лечении болезней, вызванных трихомонадидами. ! 7. Средство, содержащее нифуртимокс и противоглистный препарат. ! 8. Средство, содержащее нифуртимокс и противоглистный депсипептид.
Claims (8)
1. Применение нифуртимокса для получения лекарственных средств для лечения болезней, вызванных трихомонадидами.
2. Применение по п.1 для лечения болезней, вызванных гистомонадами.
3. Применение по п.2 для лечения болезней, вызванных Histomonas meleagridis.
4. Применение по п.1 для лечения болезней, вызванных трихомонадами.
5. Применение по п.1 для лечения болезней, вызванных тритрихомонадами.
6. Нифуртимокс для применения в лечении болезней, вызванных трихомонадидами.
7. Средство, содержащее нифуртимокс и противоглистный препарат.
8. Средство, содержащее нифуртимокс и противоглистный депсипептид.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE102008031283A DE102008031283A1 (de) | 2008-07-02 | 2008-07-02 | Neue Bekämpfungsmöglichkeit von durch Trichomonadida hervorgerufenen Krankheiten |
DE102008031283.5 | 2008-07-02 | ||
PCT/EP2009/004474 WO2010000398A1 (de) | 2008-07-02 | 2009-06-20 | Nifurtimox zur behandlung von durch trichomonadida hervorgerufenen krankheiten |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
RU2014141105A Division RU2014141105A (ru) | 2014-10-13 | 2014-10-13 | Нифуртимокс для лечения болезней, вызванных трихомонадидами |
Publications (2)
Publication Number | Publication Date |
---|---|
RU2011103476A true RU2011103476A (ru) | 2012-08-10 |
RU2538712C2 RU2538712C2 (ru) | 2015-01-10 |
Family
ID=41092164
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
RU2011103476/15A RU2538712C2 (ru) | 2008-07-02 | 2009-06-20 | Нифуртимокс для лечения болезней, вызванных трихомонадидами |
Country Status (26)
Country | Link |
---|---|
US (1) | US8440613B2 (ru) |
EP (1) | EP2310017B1 (ru) |
JP (1) | JP5571659B2 (ru) |
KR (1) | KR20110031360A (ru) |
CN (1) | CN102083440B (ru) |
AR (1) | AR072426A1 (ru) |
AU (1) | AU2009266124B2 (ru) |
CA (1) | CA2729727A1 (ru) |
CL (1) | CL2010001594A1 (ru) |
CO (1) | CO6321268A2 (ru) |
CR (1) | CR20110023A (ru) |
DE (1) | DE102008031283A1 (ru) |
DK (1) | DK2310017T3 (ru) |
DO (1) | DOP2010000406A (ru) |
EC (1) | ECSP10010721A (ru) |
ES (1) | ES2415231T3 (ru) |
IL (1) | IL209999A0 (ru) |
MX (1) | MX2010014444A (ru) |
NI (1) | NI201100009A (ru) |
PE (1) | PE20110370A1 (ru) |
PL (1) | PL2310017T3 (ru) |
RU (1) | RU2538712C2 (ru) |
SV (1) | SV2011003784A (ru) |
UA (1) | UA103197C2 (ru) |
WO (1) | WO2010000398A1 (ru) |
ZA (1) | ZA201009226B (ru) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2633855A1 (en) * | 2012-03-01 | 2013-09-04 | Veterinärmedizinische Universität Wien | Protease inhibitors for treating Trichomonas gallinae infections |
BR112017024773A2 (pt) | 2015-05-20 | 2018-11-06 | Merial, Inc. | compostos depsipeptídeos anti-helmínticos |
CA3009867C (en) | 2015-12-28 | 2022-05-31 | Merial, Inc. | Anthelmintic cyclic depsipeptide compounds |
JP6085706B1 (ja) * | 2016-03-31 | 2017-02-22 | 株式会社ポーラファルマ | 抗トリトリコモナス剤 |
WO2018093920A1 (en) | 2016-11-16 | 2018-05-24 | Merial, Inc. | Anthelmintic depsipeptide compounds |
Family Cites Families (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE1170957B (de) * | 1962-11-23 | 1964-05-27 | Bayer Ag | Verfahren zur Herstellung von 5-Nitro-furfuryliden-(2)-iminoderivaten |
NO176766C (no) * | 1989-02-07 | 1995-05-24 | Meiji Seika Kaisha | Fremgangsmåte for fremstilling av en forbindelse med anthelmintaktivitet |
JP2874342B2 (ja) | 1992-03-17 | 1999-03-24 | 藤沢薬品工業株式会社 | デプシペプチド誘導体,その製法およびその用途 |
DE4317458A1 (de) | 1992-06-11 | 1993-12-16 | Bayer Ag | Verwendung von cyclischen Depsipeptiden mit 18 Ringatomen zur Bekämpfung von Endoparasiten, neue cyclische Depsipeptide mit 18 Ringatomen und Verfahren zu ihrer Herstellung |
WO1994019334A1 (en) | 1993-02-19 | 1994-09-01 | Meiji Seika Kaisha, Ltd. | Pf1022 derivative, cyclic depsipeptide |
DE4317432A1 (de) | 1993-05-26 | 1994-12-01 | Bayer Ag | Octacyclodepsipeptide mit endoparasitizider Wirkung |
DE4317457A1 (de) | 1993-05-26 | 1994-12-01 | Bayer Ag | Octacyclodepsipeptide mit endoparasitizider Wirkung |
WO1995007272A1 (en) * | 1993-09-06 | 1995-03-16 | Fujisawa Pharmaceutical Co., Ltd. | Cyclodepsipeptide compound |
DE4401389A1 (de) * | 1994-01-19 | 1995-07-20 | Bayer Ag | Verwendung von cyclischen Depsipeptiden mit 12 Ringatomen zur Bekämpfung von Endoparasiten, neue cyclische Depsipeptide mit 12 Ringatomen und Verfahren zu ihrer Herstellung |
DE4406025A1 (de) * | 1994-02-24 | 1995-08-31 | Bayer Ag | Milchsäure-haltige cyclische Depsipeptide mit 18 Ringatomen als endoparasitizide Mittel und Verfahren zu ihrer Herstellung |
RU2074038C1 (ru) * | 1994-06-16 | 1997-02-27 | Товарищество с ограниченной ответственностью Предприятие "ТЕПАРК" | Способ изготовления полых металлических емкостей |
DE4437198A1 (de) * | 1994-10-18 | 1996-04-25 | Bayer Ag | Verfahren zur Sulfonylierung, Sulfenylierung und Phosphorylierung von cyclischen Depsipeptiden |
ATE425973T1 (de) | 1995-06-30 | 2009-04-15 | Astellas Pharma Inc | Depsipeptid-derivat, verfahren zu dessen herstellung und zwischenprodukt dafur |
DE69634961T2 (de) * | 1995-09-22 | 2006-04-20 | Bayer Ag | Neue zyklische depsipeptid pf1022 derivate |
DE19545639A1 (de) | 1995-12-07 | 1997-06-12 | Bayer Ag | Verfahren zur Herstellung von substituierten Arylmilchsäure-haltigen Cyclodepsipeptiden mit 24 Ringatomen |
US6503881B2 (en) * | 1996-08-21 | 2003-01-07 | Micrologix Biotech Inc. | Compositions and methods for treating infections using cationic peptides alone or in combination with antibiotics |
UA5478U (ru) * | 2004-06-21 | 2005-03-15 | Ігор Едуардович Лук'янов | Способ лечения урогенитального трихомониаза |
WO2006053160A2 (en) * | 2004-11-12 | 2006-05-18 | Celgene Corporation | Methods and compositions using immunomodulatory compounds for treatment and management of parasitic diseases |
-
2008
- 2008-07-02 DE DE102008031283A patent/DE102008031283A1/de not_active Withdrawn
-
2009
- 2009-06-20 WO PCT/EP2009/004474 patent/WO2010000398A1/de active Application Filing
- 2009-06-20 PL PL09772098T patent/PL2310017T3/pl unknown
- 2009-06-20 DK DK09772098.1T patent/DK2310017T3/da active
- 2009-06-20 PE PE2010001202A patent/PE20110370A1/es not_active Application Discontinuation
- 2009-06-20 UA UAA201101129A patent/UA103197C2/ru unknown
- 2009-06-20 KR KR1020117002465A patent/KR20110031360A/ko not_active Application Discontinuation
- 2009-06-20 EP EP09772098.1A patent/EP2310017B1/de not_active Not-in-force
- 2009-06-20 CA CA2729727A patent/CA2729727A1/en not_active Abandoned
- 2009-06-20 CN CN2009801255062A patent/CN102083440B/zh not_active Expired - Fee Related
- 2009-06-20 MX MX2010014444A patent/MX2010014444A/es active IP Right Grant
- 2009-06-20 JP JP2011515178A patent/JP5571659B2/ja not_active Expired - Fee Related
- 2009-06-20 US US13/000,871 patent/US8440613B2/en not_active Expired - Fee Related
- 2009-06-20 RU RU2011103476/15A patent/RU2538712C2/ru not_active IP Right Cessation
- 2009-06-20 ES ES09772098T patent/ES2415231T3/es active Active
- 2009-06-20 AU AU2009266124A patent/AU2009266124B2/en not_active Ceased
- 2009-06-30 AR ARP090102440A patent/AR072426A1/es not_active Application Discontinuation
-
2010
- 2010-12-15 IL IL209999A patent/IL209999A0/en unknown
- 2010-12-22 ZA ZA2010/09226A patent/ZA201009226B/en unknown
- 2010-12-27 EC EC2010010721A patent/ECSP10010721A/es unknown
- 2010-12-27 CO CO10162853A patent/CO6321268A2/es not_active Application Discontinuation
- 2010-12-27 DO DO2010000406A patent/DOP2010000406A/es unknown
- 2010-12-28 CL CL2010001594A patent/CL2010001594A1/es unknown
-
2011
- 2011-01-03 SV SV2011003784A patent/SV2011003784A/es unknown
- 2011-01-05 NI NI201100009A patent/NI201100009A/es unknown
- 2011-01-11 CR CR20110023A patent/CR20110023A/es not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
IL209999A0 (en) | 2011-02-28 |
CN102083440B (zh) | 2013-03-27 |
US8440613B2 (en) | 2013-05-14 |
AU2009266124B2 (en) | 2015-03-19 |
CR20110023A (es) | 2011-05-10 |
CA2729727A1 (en) | 2010-01-07 |
JP5571659B2 (ja) | 2014-08-13 |
AR072426A1 (es) | 2010-08-25 |
NI201100009A (es) | 2011-08-10 |
US20110118176A1 (en) | 2011-05-19 |
DOP2010000406A (es) | 2011-01-15 |
EP2310017B1 (de) | 2013-05-15 |
ES2415231T3 (es) | 2013-07-24 |
CN102083440A (zh) | 2011-06-01 |
DE102008031283A1 (de) | 2010-01-07 |
ECSP10010721A (es) | 2011-01-31 |
AU2009266124A1 (en) | 2010-01-07 |
PL2310017T3 (pl) | 2013-08-30 |
CO6321268A2 (es) | 2011-09-20 |
CL2010001594A1 (es) | 2011-05-06 |
WO2010000398A1 (de) | 2010-01-07 |
DK2310017T3 (da) | 2013-07-01 |
RU2538712C2 (ru) | 2015-01-10 |
SV2011003784A (es) | 2011-05-20 |
JP2011526264A (ja) | 2011-10-06 |
ZA201009226B (en) | 2012-03-23 |
UA103197C2 (ru) | 2013-09-25 |
KR20110031360A (ko) | 2011-03-25 |
MX2010014444A (es) | 2011-02-22 |
EP2310017A1 (de) | 2011-04-20 |
PE20110370A1 (es) | 2011-06-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CL2009000394A1 (es) | Compuestos derivados de n-(1h-indazol-5-il)pirrolidin-3-carboxamida sustituida, inhibidores de erk; composicion farmaceutica; y su uso en el tratamiento del cancer. | |
CL2008001114A1 (es) | Compuestos derivados de bencimidazol; composicion farmaceutica; y uso en el tratamiento de enfermedades tales como vejiga sobreactiva, dolor, obesidad, convulsiones, entre otras. | |
CO6382125A2 (es) | Inhibidores de proteína quinasa | |
CL2015000942A1 (es) | Compuestos de benceno sustituido. | |
CL2012002733A1 (es) | Compuestos derivados de ácido 1-amino-2-ciclopropiletilborónico, inhibidores de proteasoma; composición farmacéutica; uso en el tratamiento del cáncer; procedimiento de preparacion; compuestos intermediarios. | |
ECSP088358A (es) | Tratamiento y profilaxis de microangiopatías | |
NI201000164A (es) | Hidroximetil pirrolidinas como agonistas del receptor adrenérgico beta 3. | |
EA201001402A1 (ru) | Фармацевтические растворы, способ получения и терапевтическое применение | |
CL2011003147A1 (es) | Compuestos derivados de n-(1-4-(1h-pirazol-5-il)ftalazina-1-il) piperidina-4-il) benzamida; composicion farmaceutica que los contiene, utiles como antagonista de la trayectoria de hedgehog, en el tratamiento del cancer. | |
CL2008003593A1 (es) | Compuestos derivados de isoxazolo-piridazina; procedimiento de preparacion; composicion farmaceutica que comprende a dicho compuesto; y uso del compuesto en el tratamiento de trastornos cognitivos como el alzheimer | |
CL2008002369A1 (es) | Compuestos derivados de piridin-3-il-oxipiridin-2-il-amino, inhibidores de alk5; composicion farmaceutica que comprende a dicho compuesto; y uso del compuesto en el tratamiento del cancer. | |
SV2009003299A (es) | Derivados de dihidropiridina de utilidad como inhibidores de la proteina quinasa | |
CL2008000418A1 (es) | Uso de un antagonista de la il-23 para el tratamiento de una infeccion fungica. | |
CL2009000402A1 (es) | Compuestos derivados de 2-amino-acetamida sustituida; composicion farmaceutica; utiles en el tratamiento de enfermedades pulmonares, enfermedad reumatica, enfermedad autoinmune, entre otras. | |
CL2008002268A1 (es) | Compuestos derivados de amidas, moduladores del receptor taar1; proceso de obtencion; composicion farmaceutica; y uso en el tratamiento de enfermedades tales como depresion, ansiedad, estres, entre otros. | |
EA201100255A1 (ru) | 5-алкинилпиримидины | |
CL2008001820A1 (es) | Compuestos derivados de aril-isoxasol-imidazol; procedimiento de preparacion; composicion farmaceutica que los contiene; y uso en la preparacion de medicamentos utiles en el tratamiento de trastornos cognitivos y enfermedades relacionadas con alzheimer. | |
CL2008002545A1 (es) | Compuestos derivados de fenoxi-bencil-carbamoilo; composicion farmaceutica; procedimiento para preparar la composicion farmaceutica; y su uso en el tratamiento del dolor. | |
RU2011103476A (ru) | Нифуртимокс для лечения болезней, вызванных трихомонадидами | |
CL2010000281A1 (es) | Formulacion oral en forma de tableta de 9-[(2,2-dimetil-propilamino)-metil]-minociclina; metodo de preparacion; formulacion inyectable del mismo; utiles en el tratamiento de una infeccion. | |
CL2013000502A1 (es) | Compuestos derivados de-2-(1-(2(2carbonil - etil) bencil) pirrolidin-2il)-n- alquiloxazol -4 carboxamida; uso en el tratamiento de enfermedades involucrada con la respuesta anttinflamatoria en receptores de prostaglandina. | |
RU2011103475A (ru) | Новая возможность борьбы с гиардиазом | |
SV2010003578A (es) | Oxazolidinonas para el tratamiento y profilaxis de la insuficiencia cardiaca | |
CL2010001471A1 (es) | Un compuestos 2-fluoro-11-(piperazin-1.il) dibenzo´1,4 tiazepina, inhibidores net y antagonista moderado d2; procedimiento de preparacion del mismo; composicion farmaceutica; y uso en el tratamiento de trastornos psiquiatricos, entre otras enfermedades.. | |
EA201000864A1 (ru) | Фенилоксетанильные производные |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MM4A | The patent is invalid due to non-payment of fees |
Effective date: 20170621 |